BlackRock
EDIT icon

BlackRock’s Editas Medicine EDIT Stock Holding History

BlackRock’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.9M Sell
9,263,312
-83,802
-0.9% -$177K ﹤0.01% 2997
2025
Q4 		$19.2M Buy
9,347,114
+1,327,223
+17% +$3.83M ﹤0.01% 3129
2025
Q3 		$27.8M Buy
8,019,891
+1,199,037
+18% +$3.35M ﹤0.01% 2883
2025
Q2 		$15M Buy
6,820,854
+130,174
+2% +$213K ﹤0.01% 3179
2025
Q1 		$7.76M Sell
6,690,680
-617,393
-8% -$908K ﹤0.01% 3449
2024
Q4 		$9.28M Sell
7,308,073
-716,636
-9% -$1.83M ﹤0.01% 3469
2024
Q3 		$27.4M Buy
8,024,709
+242,192
+3% +$1.05M ﹤0.01% 2832
2024
Q2 		$36.3M Sell
7,782,517
-50,264
-0.6% -$284K ﹤0.01% 2602
2024
Q1 		$58.1M Sell
7,832,781
-6,188
-0.1% -$51.4K ﹤0.01% 2347
2023
Q4 		$79.4M Sell
7,838,969
-321,064
-4% -$2.82M ﹤0.01% 2219
2023
Q3 		$63.6M Buy
8,160,033
+564,337
+7% +$4.84M ﹤0.01% 2260
2023
Q2 		$62.5M Buy
7,595,696
+177,334
+2% +$1.54M ﹤0.01% 2347
2023
Q1 		$53.8M Buy
7,418,362
+79,620
+1% +$708K ﹤0.01% 2393
2022
Q4 		$65.1M Buy
7,338,742
+355,967
+5% +$3.91M ﹤0.01% 2283
2022
Q3 		$85.5M Buy
6,982,775
+258,565
+4% +$4.03M ﹤0.01% 2072
2022
Q2 		$79.5M Buy
6,724,210
+448,940
+7% +$6.02M ﹤0.01% 2178
2022
Q1 		$119M Buy
6,275,270
+841,894
+15% +$15.6M ﹤0.01% 2025
2021
Q4 		$144M Sell
5,433,376
-10,634
-0.2% -$366K ﹤0.01% 1967
2021
Q3 		$224M Sell
5,444,010
-141,179
-3% -$7.74M 0.01% 1629
2021
Q2 		$316M Sell
5,585,189
-152,187
-3% -$5.62M 0.01% 1434
2021
Q1 		$241M Buy
5,737,376
+431,970
+8% +$24.6M 0.01% 1603
2020
Q4 		$372M Sell
5,305,406
-192,869
-4% -$7.92M 0.01% 1123
2020
Q3 		$154M Buy
5,498,275
+510,595
+10% +$16.6M 0.01% 1603
2020
Q2 		$148M Buy
4,987,680
+795,631
+19% +$20.8M 0.01% 1580
2020
Q1 		$83.1M Sell
4,192,049
-49,149
-1% -$1.24M ﹤0.01% 1761
2019
Q4 		$126M Buy
4,241,198
+116,742
+3% +$2.92M ﹤0.01% 1819
2019
Q3 		$93.8M Buy
4,124,456
+251,925
+7% +$6.24M ﹤0.01% 1940
2019
Q2 		$95.8M Buy
3,872,531
+84,186
+2% +$2.01M ﹤0.01% 1938
2019
Q1 		$92.6M Buy
3,788,345
+106,811
+3% +$2.42M ﹤0.01% 1910
2018
Q4 		$83.8M Buy
3,681,534
+92,393
+3% +$2.51M ﹤0.01% 1928
2018
Q3 		$114M Buy
3,589,141
+134,075
+4% +$4.33M ﹤0.01% 1889
2018
Q2 		$124M Buy
3,455,066
+591,442
+21% +$20.9M 0.01% 1804
2018
Q1 		$94.9M Buy
2,863,624
+191,068
+7% +$6.81M ﹤0.01% 1883
2017
Q4 		$82.1M Buy
2,672,556
+33,664
+1% +$848K ﹤0.01% 1988
2017
Q3 		$63.4M Buy
2,638,892
+106,894
+4% +$2.03M ﹤0.01% 2131
2017
Q2 		$42.5M Buy
2,531,998
+1,413,510
+126% +$25.5M ﹤0.01% 2355
2017
Q1 		$25M Buy
1,118,488
+1,118,228
+430,088% +$23.2M ﹤0.01% 2626
2016
Q4 		$4K Hold
260
– – ﹤0.01% 3544
2016
Q3 		$4K Hold
260
– – ﹤0.01% 3522
2016
Q2 		$6K Hold
260
– – ﹤0.01% 3482
2016
Q1 		$9K Buy
+260
New +$6.83K ﹤0.01% 3190

Other funds holding EDIT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock's EDIT Position: Q1 2026 in Review

BlackRock reduced its Editas Medicine (EDIT) stake by 0.9% in Q1 2026, selling an estimated $177K and leaving 9,263,312 shares worth $22.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2997.

BlackRock first reported a position in EDIT in Q1 2016 and has held it in 41 quarters since. The position peaked at $372M in Q4 2020. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • BlackRock held 9,263,312 shares of Editas Medicine worth $22.9M as of Q1 2026.
  • BlackRock sold 83,802 Editas Medicine shares in Q1 2026, an estimated $177K.
  • Editas Medicine made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2997 holding.
  • BlackRock first reported a position in Editas Medicine in Q1 2016 and has held it in 41 quarters since.
  • BlackRock's Editas Medicine position peaked at $372M in Q4 2020.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.